Xospata and Oedema - a phase IV clinical study of FDA data

Summary:

Oedema is reported as a side effect among people who take Xospata (gilteritinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Prograf, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Oedema when taking Xospata. It is created by eHealthMe based on reports of 2,411 people who have side effects when taking Xospata from the FDA, and is updated regularly.

What is Xospata?

Xospata has active ingredients of gilteritinib. eHealthMe is studying from 2,411 Xospata users. Check the latest studies of Xospata.

What is Oedema?

Oedema (fluid collection in tissue) is found to be associated with 2,182 drugs and 2,311 conditions by eHealthMe. Check the latest studies of Oedema.

On Jul, 20, 2026

2,411 people reported to have side effects when taking Xospata.
Among them, 20 people (0.83%) have Oedema.

Among these 20 people:

How long have people been on Xospata when they have Oedema? *

What is the gender of people who have Oedema when taking Xospata? *

female: 44.44 %
male: 55.56 %

What is the age of people who have Oedema when taking Xospata? *

What are other drugs people take besides Xospata? *

What are other side effects people have besides Oedema? *

Weight Increased: 7 people, 35.00%
Fever: 7 people, 35.00%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 30.00%
Diarrhea: 4 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 4 people, 20.00%
Electrocardiogram Qt Prolonged: 4 people, 20.00%
Nosebleed (bleeding from nose): 3 people, 15.00%
Constipation: 3 people, 15.00%
Hepatic Function Abnormal: 3 people, 15.00%
Urine Output Decreased: 3 people, 15.00%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 9 people, 45.00%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 6 people, 30.00%
Fever: 2 people, 10.00%
Tumor Associated Fever: 1 person, 5.00%
Rectal Ulcer (ulcer of rectum): 1 person, 5.00%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 5.00%
Cytomegalovirus Infection: 1 person, 5.00%
Anorectal Abscess: 1 person, 5.00%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Xospata and have Oedema?

- Check whether Oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xospata:

Xospata (2,411 reports)

Oedema treatments and more:

Oedema (78,747 reports)

Browse all side effects of Xospata:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oedema:

Oedema (2,181 drugs)

Browse all the conditions that are associated with Oedema:

Oedema (2,311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gilteritinib (the active ingredients of Xospata) and Xospata (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.